Abecassis Michael MD is categorized under Internal Medicine Doctors in Chicago, IL and active since 2010.
Abecassis Michael MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Michael Abecassis at the company’s single location by writing to 675 North Saint Clair St # 17-200, Chicago, Illinois IL 60611 or by phoning (312) 695-8900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Abecassis Michael MD |
| Contact Person: | Michael Abecassis |
| Address: | 675 North Saint Clair St # 17-200, Chicago, Illinois 60611 |
| Phone Number: | (312) 695-8900 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Abecassis Michael MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Michael Abecassis for inquiries that concern Abecassis Michael MD by calling the company number (312) 695-8900, as your correspondence is most welcome. Additionally, the physical location of the single location of Abecassis Michael MD can be found at the coordinates 41.894262,-87.6227 as well as the street address 675 North Saint Clair St # 17-200 in Chicago, Illinois 60611.
For its online presence, you may visit Abecassis Michael MD’s website at and engage with its social media outlets through on Twitter and on Facebook.